New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Testing transgenic T cells against malignant brain tumors

Testing transgenic T cells against malignant brain tumors

byGerman Cancer Research CenterCredit: CC0 Public DomainScientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) have successfully tested a new f
World medicine December 06,2023
Testing transgenic T cells against malignant brain tumors

Testing transgenic T cells against malignant brain tumors

byGerman Cancer Research CenterCredit: CC0 Public DomainScientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) have successfully tested a new f
World medicine December 06,2023
Women with disabilities less likely to get cervical cancer screenings

Women with disabilities less likely to get cervical cancer screenings

by Amy Cherry,University of DelawareTarang Parekh, who joined UD’s epidemiology program faculty this fall, plans to launch a pilot study to determine why women with disabilities aren’t getting r
World medicine December 06,2023
Women with disabilities less likely to get cervical cancer screenings

Women with disabilities less likely to get cervical cancer screenings

by Amy Cherry,University of DelawareTarang Parekh, who joined UD’s epidemiology program faculty this fall, plans to launch a pilot study to determine why women with disabilities aren’t getting r
World medicine December 06,2023
Adopted neoplastic cells and the consequences of their existence

Adopted neoplastic cells and the consequences of their existence

by Impact Journals LLCNeoplastic adoption as a pathway of metastasis. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28408A new research perspective titled "Adopted neoplastic cell
World medicine December 06,2023
Adopted neoplastic cells and the consequences of their existence

Adopted neoplastic cells and the consequences of their existence

by Impact Journals LLCNeoplastic adoption as a pathway of metastasis. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28408A new research perspective titled "Adopted neoplastic cell
World medicine December 06,2023
Endometrial cancer risk and trends among distinct African-descent populations

Endometrial cancer risk and trends among distinct African-descent populations

by Sylvester Comprehensive Cancer Center“We need to disentangle the endometrial cancer disparities among Black women by focusing more on subpopulations, specifically on differences between countries a
World medicine December 06,2023
Endometrial cancer risk and trends among distinct African-descent populations

Endometrial cancer risk and trends among distinct African-descent populations

by Sylvester Comprehensive Cancer Center“We need to disentangle the endometrial cancer disparities among Black women by focusing more on subpopulations, specifically on differences between countries a
World medicine December 06,2023
Case report: Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

Case report: Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

by Mark Zipkin Freelance Public Relations ConsultantPARIS assay workflow including organoid generation from the fresh surgical specimen, genomic characterization, and report generation.aSc
World medicine December 06,2023
Case report: Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

Case report: Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

by Mark Zipkin Freelance Public Relations ConsultantPARIS assay workflow including organoid generation from the fresh surgical specimen, genomic characterization, and report generation.aSc
World medicine December 06,2023
How a virus causes chromosomal breakage, leading to cancer

How a virus causes chromosomal breakage, leading to cancer

byUniversity of California - San DiegoAn artistic rendering depicts the Epstein-Barr virus, which has infected more than 90% of the world's population. Credit: MobitecThe Epstein-Barr virus
World medicine December 06,2023
How a virus causes chromosomal breakage, leading to cancer

How a virus causes chromosomal breakage, leading to cancer

byUniversity of California - San DiegoAn artistic rendering depicts the Epstein-Barr virus, which has infected more than 90% of the world's population. Credit: MobitecThe Epstein-Barr virus
World medicine December 06,2023
Epigenetically guided cancer therapy: Targeting H3K27me3 loss in pediatric brain tumors

Epigenetically guided cancer therapy: Targeting H3K27me3 loss in pediatric brain tumors

by Impact Journals LLCMechanism of radiation resistance in H3K27me3-deficient medulloblastoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28427A new editorial paper titled "Tar
World medicine December 06,2023
Epigenetically guided cancer therapy: Targeting H3K27me3 loss in pediatric brain tumors

Epigenetically guided cancer therapy: Targeting H3K27me3 loss in pediatric brain tumors

by Impact Journals LLCMechanism of radiation resistance in H3K27me3-deficient medulloblastoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28427A new editorial paper titled "Tar
World medicine December 06,2023
Transgender women are still at risk for prostate cancer

Transgender women are still at risk for prostate cancer

byUniversity of California, San FranciscoCredit: Pixabay/CC0 Public DomainTransgender women keep their prostates even after gender-affirming surgery, but the extent to which they remain at risk
World medicine December 06,2023
Transgender women are still at risk for prostate cancer

Transgender women are still at risk for prostate cancer

byUniversity of California, San FranciscoCredit: Pixabay/CC0 Public DomainTransgender women keep their prostates even after gender-affirming surgery, but the extent to which they remain at risk
World medicine December 06,2023
Editorial: Subpopulations of AIB1-expressing breast cancer cells enable invasion and metastasis

Editorial: Subpopulations of AIB1-expressing breast cancer cells enable invasion and metastasis

by Impact Journals LLCGraphical representation of AIB1Δ4 enabling DCIS invasion and metastasis. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28452A new editorial paper titled "Su
World medicine December 06,2023
Editorial: Subpopulations of AIB1-expressing breast cancer cells enable invasion and metastasis

Editorial: Subpopulations of AIB1-expressing breast cancer cells enable invasion and metastasis

by Impact Journals LLCGraphical representation of AIB1Δ4 enabling DCIS invasion and metastasis. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28452A new editorial paper titled "Su
World medicine December 06,2023
Circumventing the renal toxicity associated with cisplatin treatment

Circumventing the renal toxicity associated with cisplatin treatment

by Fujita Health UniversityCredit: Unsplash/CC0 Public DomainCisplatin is widely used as a chemotherapeutic agent for the treatment of various solid tumors, including bladder, ovarian, and esophageal
World medicine December 06,2023
Circumventing the renal toxicity associated with cisplatin treatment

Circumventing the renal toxicity associated with cisplatin treatment

by Fujita Health UniversityCredit: Unsplash/CC0 Public DomainCisplatin is widely used as a chemotherapeutic agent for the treatment of various solid tumors, including bladder, ovarian, and esophageal
World medicine December 06,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com